packageMiglustat

miglustat

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Miglustat is a medicine used to treat Gaucher's disease and, in the European Union, is also authorised for Niemann-Pick diseases and glycogen storage disease type II. It is authorised in the European Union and is an approved drug, though it is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q425911 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:miglustat
ATC codes:A16AX06
DrugBank:DB00419
PubChem CID:51634
ChEBI:50381
Wikidata:Q425911
formula:C10H21NO4
molar mass:219.281 g/mol (PubChem CID 51634)
logP:-0.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown